Hermes de Jesus Garban's most recent trade in Vincerx Pharma Inc was a trade of 55,250 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vincerx Pharma Inc | Hermes de Jesus Garban | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 55,250 | 55,250 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Hermes de Jesus Garban | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) |